These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38934363)

  • 21. A functional eEF2K-eEF2 pathway in the NAc is critical for the expression of cocaine-induced psychomotor sensitisation and conditioned place preference.
    Beiser T; Lisniansky E; Weitz M; Bingor A; Grad E; Rosenblum K; Thornton C; Yaka R
    Transl Psychiatry; 2022 Nov; 12(1):460. PubMed ID: 36319619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis.
    Verpelli C; Piccoli G; Zibetti C; Zanchi A; Gardoni F; Huang K; Brambilla D; Di Luca M; Battaglioli E; Sala C
    J Neurosci; 2010 Apr; 30(17):5830-42. PubMed ID: 20427644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia.
    Moore CE; Mikolajek H; Regufe da Mota S; Wang X; Kenney JW; Werner JM; Proud CG
    Mol Cell Biol; 2015 May; 35(10):1788-804. PubMed ID: 25755286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells.
    Zhu H; Yang X; Liu J; Zhou L; Zhang C; Xu L; Qin Q; Zhan L; Lu J; Cheng H; Sun X
    Cell Stress Chaperones; 2015 Mar; 20(2):217-20. PubMed ID: 25248493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.
    De Gassart A; Demaria O; Panes R; Zaffalon L; Ryazanov AG; Gilliet M; Martinon F
    EMBO Rep; 2016 Oct; 17(10):1471-1484. PubMed ID: 27572820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eukaryotic Elongation Factor 2 Kinase a Pharmacological Target to Regulate Protein Translation Dysfunction in Neurological Diseases.
    Beretta S; Gritti L; Verpelli C; Sala C
    Neuroscience; 2020 Oct; 445():42-49. PubMed ID: 32088293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β.
    Ma T; Chen Y; Vingtdeux V; Zhao H; Viollet B; Marambaud P; Klann E
    J Neurosci; 2014 Sep; 34(36):12230-8. PubMed ID: 25186765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor.
    Chen Z; Gopalakrishnan SM; Bui MH; Soni NB; Warrior U; Johnson EF; Donnelly JB; Glaser KB
    J Biol Chem; 2011 Dec; 286(51):43951-43958. PubMed ID: 22020937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner.
    Smith EM; Proud CG
    EMBO J; 2008 Apr; 27(7):1005-16. PubMed ID: 18337751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bicuculline regulated protein synthesis is dependent on Homer1 and promotes its interaction with eEF2K through mTORC1-dependent phosphorylation.
    Gladulich LFH; Xie J; Jensen KB; Kamei M; Paes-de-Carvalho R; Cossenza M; Proud CG
    J Neurochem; 2021 May; 157(4):1086-1101. PubMed ID: 32892352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compartment-specific, differential regulation of eukaryotic elongation factor 2 and its kinase within Aplysia sensory neurons.
    Weatherill DB; McCamphill PK; Pethoukov E; Dunn TW; Fan X; Sossin WS
    J Neurochem; 2011 Jun; 117(5):841-55. PubMed ID: 21426346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress.
    Kruiswijk F; Yuniati L; Magliozzi R; Low TY; Lim R; Bolder R; Mohammed S; Proud CG; Heck AJ; Pagano M; Guardavaccaro D
    Sci Signal; 2012 Jun; 5(227):ra40. PubMed ID: 22669845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling.
    Wang X; Regufe da Mota S; Liu R; Moore CE; Xie J; Lanucara F; Agarwala U; Pyr Dit Ruys S; Vertommen D; Rider MH; Eyers CE; Proud CG
    Mol Cell Biol; 2014 Nov; 34(22):4088-103. PubMed ID: 25182533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K).
    Beretta S; Gritti L; Ponzoni L; Scalmani P; Mantegazza M; Sala M; Verpelli C; Sala C
    Mol Autism; 2022 Jan; 13(1):1. PubMed ID: 34980259
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Knight JR; Vlahov N; Gay DM; Ridgway RA; Faller WJ; Proud C; Mallucci GR; von der Haar T; Smales CM; Willis AE; Sansom OJ
    Elife; 2021 Dec; 10():. PubMed ID: 34895463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coordination of changes in expression and phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in hypertrophied cardiomyocytes.
    Kameshima S; Okada M; Ikeda S; Watanabe Y; Yamawaki H
    Biochem Biophys Rep; 2016 Sep; 7():218-224. PubMed ID: 28955910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. eEF2K/eEF2 Pathway Controls the Excitation/Inhibition Balance and Susceptibility to Epileptic Seizures.
    Heise C; Taha E; Murru L; Ponzoni L; Cattaneo A; Guarnieri FC; Montani C; Mossa A; Vezzoli E; Ippolito G; Zapata J; Barrera I; Ryazanov AG; Cook J; Poe M; Stephen MR; Kopanitsa M; Benfante R; Rusconi F; Braida D; Francolini M; Proud CG; Valtorta F; Passafaro M; Sala M; Bachi A; Verpelli C; Rosenblum K; Sala C
    Cereb Cortex; 2017 Mar; 27(3):2226-2248. PubMed ID: 27005990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroacupuncture Improves Synaptic Function in SAMP8 Mice Probably via Inhibition of the AMPK/eEF2K/eEF2 Signaling Pathway.
    Dong W; Yang W; Li F; Guo W; Qian C; Wang F; Li C; Lin L; Lin R
    Evid Based Complement Alternat Med; 2019; 2019():8260815. PubMed ID: 31641367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.
    Leprivier G; Remke M; Rotblat B; Dubuc A; Mateo AR; Kool M; Agnihotri S; El-Naggar A; Yu B; Somasekharan SP; Faubert B; Bridon G; Tognon CE; Mathers J; Thomas R; Li A; Barokas A; Kwok B; Bowden M; Smith S; Wu X; Korshunov A; Hielscher T; Northcott PA; Galpin JD; Ahern CA; Wang Y; McCabe MG; Collins VP; Jones RG; Pollak M; Delattre O; Gleave ME; Jan E; Pfister SM; Proud CG; Derry WB; Taylor MD; Sorensen PH
    Cell; 2013 May; 153(5):1064-79. PubMed ID: 23706743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myostatin inhibits eEF2K-eEF2 by regulating AMPK to suppress protein synthesis.
    Deng Z; Luo P; Lai W; Song T; Peng J; Wei HK
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):278-284. PubMed ID: 29024627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.